文献速递肺外科

肺移植与严重冠状动脉疾病:单中心经验结果

Lung transplant and severe coronary artery disease: results from a single-centre experience.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

该单中心回顾性研究分析了2010年4月至2021年2月间896例肺移植受者,其中77例(8.5%)存在严重冠状动脉疾病。严重冠状动脉疾病与死亡无关,移植前经皮腔内冠状动脉成形术或同期冠状动脉旁路移植术的患者生存率与无严重冠状动脉疾病者相当。

要点

  • 严重冠状动脉疾病在肺移植受者中占8.5%(77/896)。
  • 严重冠状动脉疾病与肺移植后死亡无关。
  • 移植前经皮腔内冠状动脉成形术或同期冠状动脉旁路移植术可用于血运重建。

核心结论

  • 严重冠状动脉疾病与肺移植后生存率降低无关。
  • 同期冠状动脉旁路移植术和移植前经皮腔内冠状动脉成形术可用于血运重建。

研究设计与样本

  • 回顾性分析本机构2010年4月至2021年2月间接受肺移植的成人患者记录。
  • 严重冠状动脉疾病定义为列名或移植前冠状动脉造影显示冠状动脉狭窄≥70%(主干≥50%)。
  • 共896例移植前接受冠状动脉造影的肺移植患者,其中77例(8.5%)有严重冠状动脉疾病,819例(91.5%)无严重冠状动脉疾病。

主要发现

  • 严重冠状动脉疾病患者年龄更大(p < 0.0001),男性更多(p < 0.0001),因肺纤维化接受移植更常见(p = 0.0007)。
  • 中位随访46(20-76)个月。
  • Cox多变量分析显示严重冠状动脉疾病与死亡无关。
  • 移植前经皮腔内冠状动脉成形术患者(p = 0.513)和同期冠状动脉旁路移植术患者(p = 0.556)生存率与无严重冠状动脉疾病患者相当。

关键数值与推荐

  • 严重冠状动脉疾病定义:冠状动脉狭窄≥70%(主干≥50%)。
  • 严重冠状动脉疾病组77例(8.5%),无严重冠状动脉疾病组819例(91.5%)。
  • 中位随访46(20-76)个月。
  • 移植前经皮腔内冠状动脉成形术患者生存率与无严重冠状动脉疾病患者比较p = 0.513。
  • 同期冠状动脉旁路移植术患者生存率与无严重冠状动脉疾病患者比较p = 0.556。

临床怎么用

  • 同期冠状动脉旁路移植术和移植前经皮腔内冠状动脉成形术可用于血运重建。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The management of severe coronary artery disease at the time of a lung transplant remains a challenge. We analysed the short- and long-term outcomes of lung transplant recipients with severe coronary artery disease. METHODS: Records of adult patients who received transplants at our institution between April 2010 and February 2021 were reviewed retrospectively. Severe coronary artery disease was defined as coronary stenosis ≥70% (main stem ≥50%) seen on the coronary angiographic scans performed before or at the time of listing. Patient characteristics, perioperative and long-term outcomes were compared between patients with and without severe coronary artery disease. RESULTS: Among 896 patients who received lung transplants who had undergone coronary angiography before the transplant, 77 (8.5%) had severe coronary artery disease; the remaining 819 (91.5%) did not. Patients with severe coronary artery disease were older (p < 0.0001), more often male (p < 0.0001) and received transplants more often for pulmonary fibrosis (p = 0.0007). The median (interquartile range) follow-up was 46 (20-76) months. At the Cox multivariable analysis, severe coronary artery disease was not associated with death. Patients with pretransplant percutaneous transluminal coronary angioplasty and patients with coronary artery bypass graft surgery concomitant to a transplant had survival equivalent to that of patients without severe coronary artery disease (p = 0.513; p = 0.556). CONCLUSIONS: Severe coronary artery disease was not associated with decreased survival after a lung transplant. Concomitant coronary artery bypass graft surgery and pretransplant percutaneous transluminal coronary angioplasty can be used for revascularization.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Franz M, Siemeni T, Aburahma K, et al. Lung transplant and severe coronary artery disease: results from a single-centre experience. Eur J Cardiothorac Surg. 2022. PMID: 35703921. doi:10.1093/ejcts/ezac348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。